Gynecologic oncology focuses on cancers of the female reproductive system and integrates prevention, screening, surgery, systemic therapy, radiation, molecular diagnostics, and hereditary cancer management. This session highlights clinical and scientific advances aimed at improving outcomes across gynecologic malignancies.
Abstract Scope and Participation
Abstracts may cover ovarian, cervical, endometrial, uterine, vulvar, vaginal, and related cancers, including hereditary risk, biomarkers, surgery, chemotherapy, targeted therapy, immunotherapy, radiation, and survivorship. Gynecologic oncologists, researchers, surgeons, pathologists, geneticists, and allied professionals are encouraged to participate.
Ovarian Cancer (OC) is the 3rd most common gynecological cancer worldwide with high morbidity and mortality rate and Epithelial Ovarian Cancer (EOC) is the most common subtype (90%). Despite advances…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Gynecologic Oncology work, reviewed by the scientific committee.
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Gynecologic Oncology research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Gynecologic Oncology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gynecologic Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Cancer researchers and clinicians, educators and students with an interest in Gynecologic Oncology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. CIOC 2027 is a hybrid conference — attend the Gynecologic Oncology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
